Talk to a healthcare professionals 1-855-899-2873

Search

Cancerous tumours

Cancerous tumours

Cancerous tumors

Prostate cancer is a disease that generally progresses at a fairly slow pace and, when detected early, is highly curable. In the majority of cases, when detected at a localized stage, that is to say in the absence of it spreading to other parts of the body (metastasis), the survival rate is excellent. That’s why early detection is important.
 

Illustration de l’appareil de l’homme pour un cancer prostate

Nowadays, advanced techniques are used to produce an extremely accurate diagnosis. In addition, multiple effective therapeutic approaches can halt or slow the progression of the disease. In most cases, the prognosis is encouraging.

Prostate cancer is the most common form of cancer in men. It is sometimes indolent, sometimes fatal and it causes little or no symptoms at first. Although it strikes on average around the age of 67, it can affect men in their forties or fifties. In Quebec, nineteen (19) men are diagnosed daily.

Although the incidence of prostate cancer continues to increase, the latest advances in treatment have reduced the risk of death. Indeed, considerable progress has been made in terms of invasive surgeries or specific radiation therapies to treat certain forms of prostate cancer, which in turn has reduced the risk of complications and has allowed for a faster recovery.

The exact causes of prostate cancer remain largely unknown. However, research has highlighted some risk factors.

Generally speaking, cancer is characterized by uncontrolled growth of abnormal cells. It can affect any type of cell in an organ, a gland, muscle tissue, blood or the lymphatic system.

Under normal conditions, the cells in our bodies contain all the information they need for their development, function, reproduction and death. Usually, our cells do their work properly and we remain healthy. However, sometimes a few of the cells do not behave normally and begin multiplying uncontrollably, eventually forming a group of abnormal cells. After a while, this group forms a detectable lump known as a tumour.

Over time, the malignant cells in cancerous tumours can invade neighbouring tissue or organs. They may even spread to the rest of the body through the blood or lymphatic system. This stage is known as “metastasis.”

In the case of prostate cancer, the secretory cells are usually the ones that become cancerous. Once the cancer has been diagnosed, treatment is determined depending on the stage of the disease and the overall health of the patient.

Types of prostate cancer

Prostate cancer is a very heterogeneous disease, some progress very slowly while others are more aggressive. In reality, most cases are somewhere between the two. For the moment, science does not have the tools to accurately predict the growth rate of a person’s cancer once it has been diagnosed. Clinicians use a variety of information to estimate the speed of the cancer.

About 14 percent of Canadians suffer from “clinical” prostate cancer, meaning their disease has been detected by a doctor and officially diagnosed. However, studies of autopsy reports have shown that another 30 percent of men have latent cancer, meaning the cancerous cells lie dormant in the prostate. Although present, the cancer does no harm because it does not attack the body. Not all men develop latent prostate cancer, but the probability of doing so increases with age.

According to the current state of knowledge, prostate cancer is one of the few cancers that can remain in latent form for such a long period of time. Researchers are trying to understand why some cancers remain latent while others develop into full-blown diseases. While it is generally believed that risk factors and genes play an important role in the development of clinically significant cancer, the precise mechanism is still unknown.

Other pages that might interest you

Additional Information - Prostate diseases

#

Urologist’s advice: Treatments and information on prostate cancer

Learn more about the role of the urologist and the importance for a patient to gather adequate information after receiving a prostate cancer diagnosis.

Read the article
#

How I coped with prostate cancer

A man with prostate cancer shares the challenges of his cancer experience.

Read the article
#

Genetics and prostate cancer

Do you have a family history of cancer? Your doctor might recommend genetic screening.

Watch the Video
#

Symptoms, risk and screening

Are you over 50 or experiencing urinary problems? Discover why early screening for prostate diseases is important.

Watch the Video
#

Prostate cancer prognosis and survival

After a prostate cancer diagnosis, questions about survival, cure rates, and quality of life can arise.  

Read the article
#

Prostate cancer: Tests, imaging and biomarkers

This webinar covers various tests and exams for diagnosing and monitoring prostate cancer.  

Read the article
#

Biopsy: Understanding your report

This webinar clarifies biopsy reports, pathologists’ roles, and how results confirm or rule out prostate cancer.  

Read the article
#

Your prognosis and survival

After receiving a diagnosis of prostate cancer, you will undoubtedly have questions about your prognosis and survival and will want to know the chances of success with your treatment.

Read the article
#

What is a genetic mutation?

Do you have a significant family history of cancer? Is there a link between prostate cancer and a genetic mutation?

Read the article
#

Finding the right words

Prostate cancer often overwhelms patients. Finding the right words is crucial to comfort and support them.

Read the article

Sources and references
Last medical and editorial review: April 2024. See our web page validation committee and our collaborators by clicking here.

Prostate cancer
do not experience it alone.

Our healthcare professionals are here to answer all your questions and those of your loved ones. Contact us.

7/7 toll-free support line

1-855-899-2873

Contact Us
© 2023 PROCURE – All rights reserved | Registration number: 86394 4955 RR0001

Terms of use | Privacy policy